Emergence of community-acquired Clostridium difficile infection: The experience of a French hospital and review of the literature

International Journal of Infectious Diseases

Volumn 37, Issue , 2015, Pages 36-41

  Ogielska, Maja ^a   Lanotte, Philippe ^b   Le Brun, Cécile ^b   Valentin, Anne Sophie ^a   Garot, Denis ^a   Tellier, Anne Charlotte ^a   Halimi, Jean Michel ^a   Colombat, Philippe ^a   Guilleminault, Laurent ^a   Lioger, Bertrand ^a   Vegas, Hélène ^a   De Toffol, Bertrand ^a   Constans, Thierry ^a   Bernard, Louis ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Clostridium difficile; Clostridium Severity Index score; Community infection; Proton pump inhibitors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; MACROLIDE; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM SEVERITY INDEX; COMMUNITY ACQUIRED INFECTION; DIARRHEA; DISEASE SEVERITY; FEMALE; FRANCE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INTENSIVE CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; RATING SCALE; RISK FACTOR; ADOLESCENT; CLOSTRIDIUM INFECTION; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; EMBRYOLOGY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DIARRHEA; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84936754478     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.06.007     Document Type: Article

References (24)

1. Kyne I., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial diarrhoea due to Clostridium difficile. Clin Infect Dis 2002, 34:346-353.
2. Bishara J., Farah R., Mograbi J., Khalaila W., Abu-Elheja O., Mahamid M., et al. Obesity as risk factor for Clostridium difficile infection. Clin Infect Dis 2013, 57:489-493.
3. Dial S., Delaney J.A., Barkun A.N., Suissa S. Use of gastric acid-suppressive agents and risk of community-acquired Clostridium difficile-associated disease. JAMA 2005, 294:2989-2995.
4. Chitnis A.S., Holzbauer S.M., Belflower R.M., Winston L.G., Bamberg W.M., Lyons C., et al. Epidemiology of community-associated Clostridium difficile infection, 2009 thought 2011. JAMA Intern Med 2013, 173:1359-1367.
5. Pant C.H., Sferra T.J., Deshpande A., Minocha A. Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner. Eur J Intern Med 2011, 22:561-568.
6. Lungulescu O.A., Cao W., Gatskevich E., Tlhabano L., Stratidis J.G. CSI: A severity index for Clostridium difficile infection at the time of admission. J Hosp Infect 2011, 79:151-154.
7. Kuntz J.L., Chrischilles E.A., Pendergast J.F., Herwaldt L.A., Polgreen P.M. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 2011, 11:194.
8. Lessa F.C. Community-associated Clostridium difficile infection: how real is it?. Anaerobe 2013, 24:121-123.
9. Dumyati G., Stevens V., Hannett G.E., Thompson A.D., Long C., MacCannell D., et al. Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg Infect Dis 2012, 18:392-400.
10. Goossen H., Ferech M., Stichele R.V., Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:579-587.
11. Arora V., Kachroo S., Ghantoji S.S., DuPont H.L., Garey K.W. High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection. J Hosp Infect 2011, 79:23-26.
12. Eyre D.W., Walker A.S., Wyllie D., Dingle K.E., Griffiths D., Finney J., et al. Predictors of first recurrence of Clostridium difficile infection: implication for initial management. Clin Infect Dis 2012, 55(Suppl 2):S77-S87.
13. Nerandzic M.M., Pultz M.J., Donskey C.J. Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection. Antimicrob Agents Chemother 2009, 53:4133-4137.
14. Kutty P.K., Woods C.W., Sena A.C., Benoit S.R., Naggie S., Joyce F., et al. Risk Factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010, 16:197-204.
15. Riley T.V., Wymer V., Bamford V.W., Bowman R.A. Clostridium difficile in general practice and community health. J Hyg (Lond) 1986, 96:13-17.
16. Hirschhorn L.R., Trnka Y., Onderdonk A., Lee M.L., Platt R. Epidemiology of community-acquired Clostridium difficile associated diarrhea. J Infect Dis 1994, 169:127-133.
17. Clohessy P., Merif J., Post J.J. Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary hospital campus. Int J Infect Dis 2014, 29:152-155.
18. Lessa F.C., Mu Y., Bamberg W.M., Beldavs Z.G., Dumyati G.K., Dunn J.R., et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015, 372:825-834.
19. Rodríguez-Pardo D., Almirante B., Bartolomé R.M., Pomar V., Mirelis B., Navarro F., et al. Barcelona Clostridium difficile Study Group. Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol 2013, 51:1465-1473.
20. Karlstrom O., Fryklund B., Tullus K., Burman L.G. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis 1998, 26:141-145.
21. Kyne L., Merry C., O'Connell B., Keane C., O'Neill D. Community-acquired Clostridium difficile infection. J Infect 1998, 36:287-288.
22. Beaugerie L., Flahault A., Barbut F., Atlans P., Lalande V., Cousin P., et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003, 17:905-912.
23. Wilcox M.H., Mooney L., Bendall R., Settle C.D., Fawley W.N. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008, 62:388-396.
24. Bauer M.P., Veenendaal D., Verhoef L., Bloembergen P., Van Dissel J.T., Kuijper E.J. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands. Clin Microbiol Infect 2009, 15:1087-1092.